These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 19159701

  • 1. Critical issues of PTH assays in CKD.
    Komaba H, Goto S, Fukagawa M.
    Bone; 2009 Apr; 44(4):666-70. PubMed ID: 19159701
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. [Parathormone and chronic kidney disease].
    Bacchetta J, Jolivot A, Souberbielle JC, Charrié A, Guebre F, Chauvet C, Fouque D.
    Nephrol Ther; 2007 Jul; 3(4):133-8. PubMed ID: 17658439
    [Abstract] [Full Text] [Related]

  • 4. Measurement of parathyroid hormone.
    Endres DB, Villanueva R, Sharp CF, Singer FR.
    Endocrinol Metab Clin North Am; 1989 Sep; 18(3):611-29. PubMed ID: 2673765
    [Abstract] [Full Text] [Related]

  • 5. Immunoassays for the detection of parathyroid hormone.
    Jüppner H, Potts JT.
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N81-6. PubMed ID: 12412782
    [Abstract] [Full Text] [Related]

  • 6. Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study.
    Melamed ML, Eustace JA, Plantinga LC, Jaar BG, Fink NE, Parekh RS, Coresh J, Yang Z, Cantor T, Powe NR.
    Nephrol Dial Transplant; 2008 May; 23(5):1650-8. PubMed ID: 18065788
    [Abstract] [Full Text] [Related]

  • 7. Overproduction and secretion of a novel amino-terminal form of parathyroid hormone from a severe type of parathyroid hyperplasia in uremia.
    Arakawa T, D'Amour P, Rousseau L, Brossard JH, Sakai M, Kasumoto H, Igaki N, Goto T, Cantor T, Fukagawa M.
    Clin J Am Soc Nephrol; 2006 May; 1(3):525-31. PubMed ID: 17699255
    [Abstract] [Full Text] [Related]

  • 8. Evolution of the parathyroid hormone (PTH) assay--importance of circulating PTH immunoheterogeneity and of its regulation.
    Gao P, D'Amour P.
    Clin Lab; 2005 May; 51(1-2):21-9. PubMed ID: 15719701
    [Abstract] [Full Text] [Related]

  • 9. [PTH measurement: where do we stand?].
    Marangella M.
    G Ital Nefrol; 2009 May; 26(5):600-7. PubMed ID: 19802805
    [Abstract] [Full Text] [Related]

  • 10. High third generation/second generation PTH ratio in a patient with parathyroid carcinoma: clinical utility of third generation/second generation PTH ratio in patients with primary hyperparathyroidism.
    Caron P, Maiza JC, Renaud C, Cormier C, Barres BH, Souberbielle JC.
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):533-8. PubMed ID: 18782355
    [Abstract] [Full Text] [Related]

  • 11. Comparison of C-terminal and N-terminal PTH in secondary hyperparathyroidism in renal failure.
    Hortling L, Puutula-Räsänen L, Fyhrquist F.
    Scand J Urol Nephrol Suppl; 1985 Apr; 90():51-4. PubMed ID: 3868028
    [Abstract] [Full Text] [Related]

  • 12. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R, Li S, Chen SC, McCullough PA, Bakris GL.
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [Abstract] [Full Text] [Related]

  • 13. Comments on plasma parathyroid hormone levels and their relationship to bone histopathology among patients undergoing dialysis.
    Goodman WG.
    Semin Dial; 2007 Apr; 20(1):1-4. PubMed ID: 17244110
    [Abstract] [Full Text] [Related]

  • 14. [Bone and bone related biochemical examinations. Hormone and hormone related substances. Parathyroid hormone].
    Tanaka M, Fukagawa M.
    Clin Calcium; 2006 Jun; 16(6):927-34. PubMed ID: 16751687
    [Abstract] [Full Text] [Related]

  • 15. Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry.
    Lehmann G, Stein G, Hüller M, Schemer R, Ramakrishnan K, Goodman WG.
    Kidney Int; 2005 Sep; 68(3):1206-14. PubMed ID: 16105052
    [Abstract] [Full Text] [Related]

  • 16. Recent advances in parathyroid disease and parathyroid hormone assays.
    Garon JE, Liu N.
    Clin Leadersh Manag Rev; 2002 Sep; 16(3):187-91. PubMed ID: 12046277
    [Abstract] [Full Text] [Related]

  • 17. [Significance of a new PTH assay (the comparison between whole-PTH and intact-PTH assay)].
    Ito N, Fukumoto S.
    Clin Calcium; 2004 Sep; 14(9):55-6. PubMed ID: 15577110
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of PTH IRMA kit (allegro intact PTH) for measurement of serum PTH concentration].
    Togashi K, Sakamaki H, Abe A, Tsukamoto Y, Marumo F.
    Rinsho Byori; 1989 Jun; 37(6):702-6. PubMed ID: 2795917
    [No Abstract] [Full Text] [Related]

  • 19. Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis.
    Salusky IB, Goodman WG, Kuizon BD, Lavigne JR, Zahranik RJ, Gales B, Wang HJ, Elashoff RM, Jüppner H.
    Kidney Int; 2003 May; 63(5):1801-8. PubMed ID: 12675856
    [Abstract] [Full Text] [Related]

  • 20. CKD patients: the dilemma of serum PTH levels.
    Pontoriero G, Cozzolino M, Locatelli F, Brancaccio D.
    Nephron Clin Pract; 2010 May; 116(4):c263-8. PubMed ID: 20639672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.